Harmony Biosciences Holdings, Inc. (HRMY) stock
HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.11+0.10 (+0.30%)
Close on Nov 18, 2026Market cap $1.93BP/E 10.7Yield –
Harmony Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Harmony Biosciences's market cap was $1.99B on Nov 11, 2026, against $2.03B a year earlier. Over the last 5 years it ranged from $1.41B to $3.54B, with a median of $2.04B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.99B | -7.7% |
| 2025 | Dec 31, 2025 | $2.16B | +9.8% |
| 2024 | Dec 31, 2024 | $1.96B | +3.7% |
| 2023 | Dec 29, 2023 | $1.89B | -42.1% |
| 2022 | Dec 30, 2022 | $3.27B | +31.2% |
| 2021 | Dec 31, 2021 | $2.49B | +21.1% |
| 2020 | Dec 31, 2020 | $2.06B | – |
See a number that looks wrong?